Download the BEI Playbook and position your brand to enter the first federal hemp channel into Medicare:
TruCBN™ is the only hemp-derived ingredient on the market today with published peer-reviewed clinical evidence for sleep and safety, which matters because adoption inside the BEI program does not come from a single decision. It comes from three: the ACO needs to approve the product, the physician needs to recommend it, and the patient needs to trust it. TruCBN™ gives your brand what it takes to clear all three.
TruCBN™ gives ACO medical directors a defensible cost-of-care argument for sleep. Peer-reviewed clinical and real-world evidence support meaningful sleep improvement in a non-impairing format, which addresses patient complaints while reducing downstream cost categories that drive ACO losses. For an ACO operating on shared savings, that creates a credible path to reducing total cost of care across the Medicare panel.
TruCBN™ gives physicians the documentation they need to lead a defensible shared decision-making conversation. The package covers the core areas that conversation has to address: how the product is expected to help the patient, what potential side effects to watch for, and what guidance to provide on drug interactions. That gives physicians the confidence to recommend, defend, and document the choice.
What older patients want from a sleep solution is straightforward: fall asleep, stay asleep, wake up clear-headed, and not worry that what they are taking will become a habit or interfere with their other medications. TruCBN™ delivers on every one of those needs. When the recommendation comes from their physician, patients can trust the product because the science behind it earned the physician's trust first.